Transgenderism Clinical Trial
— TRANSPELVOfficial title:
Prospective Imaging Assessment of Perineo-pelvic Static's Evolution After Sexual Reassignment Surgery in MtF Transgender Patient, by Peno-scrotal Inversion Vaginoplasty Technique (TRANSPELV)
Verified date | May 2024 |
Source | University Hospital, Limoges |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The research consists of adding to the usual MtF transgender patient undergoing vaginoplasty care course, static and dynamic perineo-pelvic MRI before, and at 6 and 24 months. The aim is to assess perineo-pelvic static's evolution, based on the appearance of a rectocele.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | July 15, 2026 |
Est. primary completion date | September 8, 2024 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patient over 18 years old - Patient admitted in urology ward at Limoges' University Hospital for MtF sexual reassignment surgery by vaginoplasty - Patient affiliated or benefitting from a social security system - Patient free, informed, written and signed consent Exclusion Criteria: - Patient admitted for vulvoplasty surgery - Patient admitted for second vaginoplasty surgical gesture - Contraindication of realizing an MRI |
Country | Name | City | State |
---|---|---|---|
France | University Hospital, Limoges | Limoges |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Limoges |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Measurement comparison of the rectal bulge's size and classification | Comparison and classification by pre-operative and post-operative MRI | 6 months and 24 months | |
Secondary | Rectocele | Describe the rectocele's mean size and it's progress | 6 months and 24 months | |
Secondary | Rectocele | Describe the rectocele size's progress by class | 6 months and 24 months | |
Secondary | Reproducibility in the rectocele's measurement | Evaluate intra and inter-operator reproducibility in the rectocele's measurement | 6 months and 24 months | |
Secondary | Symptomatology pelvic fixity | Evaluate correlation between symptomatology and the rectocele assessment | 6 months and 24 months | |
Secondary | Factors pelvic fixity | Evaluate correlation between factors and the rectocele assessment | 6 months and 24 months | |
Secondary | Skin-graft's neo-vagina's sizes | Evaluate correlation between the skin-graft's size in cm² and the neo-vagina's sizes (lenght, width) in cm | 6 months and 24 months | |
Secondary | Imaging measures | Evaluate modifications of imaging measures size in cm² and the neo-vagina's sizes (lenght, width) in cm | 6 months and 24 months | |
Secondary | Urinary quality | Evaluate evolution of unrinary quality of life with Urinary Symptom Profile (USP) score, from 0 (best) to 39 (worst) | 6 months and 24 months | |
Secondary | Self-imaging | Evaluate evolution of self-imaging with Body Image (BI-1) score, from 30 (no change) to 150 (change) ; and Female Genital Self-Image Scale (FGSIS) score, from 7 (worst) to 28 (best) | 6 months and 24 months | |
Secondary | Sexual quality | Evaluate evolution of sexual quality of life with Operated Male-to-Female Sexual Function Index (OmtFSFI) score, from 18 (best) to 72 (worst) | 6 months and 24 months | |
Secondary | Post-operative issues | Epidemiologic census of post-operative issues | Instantly, 6 months and 24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04977765 -
Cardiometabolic Health in Transgender Males
|
||
Recruiting |
NCT06074796 -
The Determinants of Fertility Preservation in TRANSgender Patients.
|
||
Completed |
NCT04454970 -
Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction
|
N/A | |
Completed |
NCT04708600 -
Effectiveness of Speech Therapy in Trans Women.
|
N/A | |
Terminated |
NCT04551144 -
Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
|
||
Completed |
NCT04545450 -
Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen
|
Phase 3 | |
Recruiting |
NCT05663892 -
Drug-Drug Interaction Study in Trans Women Living With HIV
|
Phase 4 | |
Completed |
NCT05666102 -
Transgender Men's Perspectives on HIV Risk and HIV Prevention Interventions
|
N/A | |
Recruiting |
NCT04838249 -
Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
|
||
Not yet recruiting |
NCT06434805 -
An Education Initiative to Reduce Stigma Towards Sex Workers and Sexual Minorities Among Nursing Students
|
N/A | |
Recruiting |
NCT05883553 -
Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients.
|
N/A | |
Not yet recruiting |
NCT04154358 -
Implementing HPV DNA Self-Collection to Increase Rates of Cervical Cancer Screening in Transgender Men
|
N/A | |
Recruiting |
NCT04254354 -
Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC
|
||
Completed |
NCT04969003 -
Reducing Transphobia Among Adolescents Through a Brief Video Intervention
|
N/A | |
Completed |
NCT06149065 -
Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study
|
||
Not yet recruiting |
NCT06443164 -
Efficacy of a Chronic Pain Treatment Prior to Gender-affirming Surgery
|
N/A | |
Not yet recruiting |
NCT06450405 -
Androgen Effects on the Reproductive Neuroendocrine Axis
|
||
Terminated |
NCT04275310 -
Microeconomic Intervention to Reduce HIV Transmission in Economically Disadvantaged Transgender Women
|
N/A | |
Not yet recruiting |
NCT05415930 -
Evaluation of an Adaptative, Multidisciplinary, Reach-out Program, Facilitating Pre Exposition HIV Prophylaxis (PrEP) Prescription and Retention in Care, in a Group of Trans Womens (TW) at High Risk of HIV Infection.
|
||
Completed |
NCT04515654 -
Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre: Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre
|
N/A |